These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9008252)

  • 1. Angiotensin converting enzyme inhibition corrects Na+/H+ exchanger overactivity in essential hypertension.
    Fortuño A; Tisaire J; López R; Bueno J; Díez J
    Am J Hypertens; 1997 Jan; 10(1):84-93. PubMed ID: 9008252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Na(+)-H+ exchanger activity and NHE-1 mRNA expression in lymphocytes from patients with essential hypertension.
    Garciandia A; López R; Tisaire J; Arrázola A; Fortuño A; Bueno J; Diez J
    Hypertension; 1995 Mar; 25(3):356-64. PubMed ID: 7875760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
    Larochelle P
    Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte anion exchanger activity and intracellular pH in essential hypertension.
    Alonso A; Arrázola A; Garciandía A; Esparza N; Gómez-Alamillo C; Díez J
    Hypertension; 1993 Sep; 22(3):348-56. PubMed ID: 8394284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinapril treatment enhances vascular sensitivity to insulin.
    Feldman RD; Schmidt ND
    J Hypertens; 2001 Jan; 19(1):113-8. PubMed ID: 11204290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.
    Arvola P; Ruskoaho H; Wuorela H; Pekki A; Vapaatalo H; Pörsti I
    Br J Pharmacol; 1993 Apr; 108(4):980-90. PubMed ID: 8485636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J; Laviades C
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitivity, glucose effectiveness, and beta-cell function in obese males with essential hypertension: investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril).
    Cabezas-Cerrato J; Garcia-Estevez DA; Araújo D; Iglesias M
    Metabolism; 1997 Feb; 46(2):173-8. PubMed ID: 9030825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
    MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
    Frishman WH; Greenberg S
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma digoxin immunoreactivity and arterial potassium relaxation after quinapril therapy in hypertensive rats.
    Kähönen M; Doris PA; Mäkynen H; Pörsti I
    J Pharmacol Exp Ther; 1995 Nov; 275(2):832-7. PubMed ID: 7473173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term antihypertensive therapy with angiotensin converting enzyme inhibitors on red cell sodium transport.
    de la Sierra A; Insa R; Compte M; Martínez-Amenós A; Sierra C; Hernández-Herrero G; Coca A
    Am J Hypertens; 1995 Jun; 8(6):622-5. PubMed ID: 7662247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM].
    Motero Carrasco J
    Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of increased erythrocyte Na+/H+ exchanger with renal Na+ retention in patients with essential hypertension.
    Díez J; Alonso A; Garciandía A; López R; Gómez-Alamillo C; Arrázola A; Fortuño A
    Am J Hypertens; 1995 Feb; 8(2):124-32. PubMed ID: 7755940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.